Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Older people

No benefit to daily aspirin in healthy older people

Despite widespread use of low-dose aspirin, a placebo-controlled trial of almost 20,000 people found no benefit of the drug in healthy older people.

old man pouring pills into his hand

Source: Shutterstock.com

Researchers have found that aspirin use in healthy older people does not prolong disability-free survival over a period of five years

Daily low-dose aspirin does not increase the duration of disability-free life in healthy older people, trial results published in the New England Journal of Medicine (16 September 2018) have shown[1].

The study involved 19,114 people in the United States and Australia with a median age of 74 years who did not have cardiovascular disease, dementia or physical disability. Of these, 9,525 participants were randomly assigned to receive 100mg of enteric-coated aspirin daily and 9,589 participants to an oral placebo. Individuals were followed-up for a median of 4.7 years.

The researchers found no significant difference between the two groups regarding the primary end point of death, dementia or persistent physical disability (21.5 versus 21.2 events per 1,000 person–years, respectively). However, the rate of major haemorrhage was significantly elevated by 38% among those taking aspirin compared with placebo (3.8% vs 2.8%).

The researchers noted that despite the widespread use of low-dose aspirin among older people, the evidence base is not strong enough to support this practice in individuals who have not previously experienced a cardiovascular event.

“Aspirin use in healthy [older people] did not prolong disability-free survival over a period of five years but led to a higher rate of major haemorrhage than placebo,” the team concluded.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205506

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £25.00Buy now
  • Introduction to Statistics in Pharmaceutical Clinical Trials

    Introduction to Statistics in Pharmaceutical Clinical Trials

    An innovative book which presents statistics in the context of clinical trials conducted during pharmaceutical drug development.

    £38.00Buy now
  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Pharmacy OSCEs

    Pharmacy OSCEs

    The only pharmacy-specific OSCE revision guide. This easy-to-use book covers the key competencies that will be tested in your exams.

    £25.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • old man pills ss 18

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.